Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Heba W Alhamdi,Mohammad Y Alfaifi,Ali A Shati,Serag Eldin I Elbehairi,Mohammed Er-Rajy,Reda F M Elshaarawy,Yasser A Hassan,Rozan Zakrya

DOI: https://doi.org/10.1039/d4ra90101k

2024-09-19

Abstract:[This corrects the article DOI: 10.1039/D4RA04219K.].

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Heba W Alhamdi,Mohammad Y Alfaifi,Ali A Shati,Serag Eldin I Elbehairi,Mohammed Er-Rajy,Reda F M Elshaarawy,Yasser A Hassan,Rozan Zakrya

DOI: https://doi.org/10.1039/d4ra04219k

2024-09-06

Abstract:Recently, molecular hybrids of two or more active pharmacophores have shown promise for designing and synthesizing anticancer drugs. Herein, a new multifunctional hybrid (PAHMQ), combining azobenzene and quinoline pharmacophores, and its M(ii) complexes (MPAHMQ) have been successfully developed and structurally characterized. The MTT assay revealed CuBHTP as the most efficient and safe breast cancer treatment, with an IC50 of 11.18 ± 0.39 μg mL-1 and a high selectivity index (SI) of 5.63 for cancer MCF-7 cells over healthy MCF10A cells. Moreover, the CuPAHMQ-treated MCF-7 cells experience a dramatic impact with regard to key apoptotic markers, including an increase in P53 and Bax expression, with a decrease in Bcl-2 expression levels compared to the untreated MCF-7 cells. Additionally, CuPAHMQ effectively halted the growth and division of MCF-7 cells by inducing cell cycle arrest in the crucial G1 and S phases, ultimately inhibiting both Topo II activity and cell proliferation. Molecular docking investigations validated the CuPAHMQ complex's groove binding and topoisomerase II binding, establishing it as a potent anticancer drug.
Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Nilesh Raghunath Khedkar,Milind Sindkhedkar,Alex Joseph

DOI: https://doi.org/10.1039/d4md90040e

2024-10-15

Abstract:[This corrects the article DOI: 10.1039/D4MD00055B.].
Correction To: Methylseleninic Acid Suppresses Breast Cancer Growth Via the JAK2/STAT3 Pathway

Tao Zhang,Xinying Zhu,Jinxia Qiu,Kangfeng Jiang,Gan Zhao,Haichong Wu,Ganzhen Deng,Changwei Qiu

DOI: https://doi.org/10.1007/s43032-020-00353-w

2020-01-01

Reproductive Sciences

Abstract:Due to an unfortunate oversight, author names have been misspelt.
Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Mostafa Heidari Majd,Xiangyu Guo

DOI: https://doi.org/10.2174/187152062405240209150030

IF: 2.8

2024-02-01

Anti-Cancer Agents in Medicinal Chemistry

Abstract:A typographical error appeared in the author affiliation titled “Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells”, published in Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(15) [1]. Details of the error and a correction are provided here. Original: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital Chinese Academy of Medical Science, Liaoning Provincial Cancer Hospital, Shenyang, Liaoning, 110042, China Corrected: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China We regret the error and apologize to readers. The original article can be found online at https://www.eurekaselect.com/article/131718

oncology,chemistry, medicinal
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Correction to “Homobimetallic Au(I)–Au(I) and Heterotrimetallic Au(I)–Fe(II)–Au(I) Complexes with Dialkyldithiophosphates and Phosphine Ligands: Structural Characterization, DFT Analysis, and Tyrosinase Inhibitory and Biological Effects”

Abdollah Neshat,Atiyeh Mahdavi,Mohammad Reza Yousefshahi,Mahdi Cheraghi,Ali Mousavizadeh Mobarakeh,Saiedeh Mohammadi,Vaclav Eigner,Monika Kucerakova,Michal Dusek,Babak Kaboudin

DOI: https://doi.org/10.1021/acsomega.3c04598

IF: 4.1

2023-07-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00645.].

chemistry, multidisciplinary
Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian,Meimei Zhao,Qinghua Han,Jingkang Wang,Lixi Liao,Heng Yang,Dan Liu,Pengfei Tu,Hong Liang,Kewu Zeng

DOI: https://doi.org/10.1016/j.apsb.2024.02.013

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.01.011.].
Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

Burhan Ul Haq,Hina Qayoom,Shazia Sofi,Nusrat Jan,Aisha Shabir,Irshad Ahmad,Fuzail Ahmad,Abdullah Almilaibary,Manzoor A Mir

DOI: https://doi.org/10.3389/fphar.2024.1494110

2024-09-30

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1333447.].
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters

Mengjun Zhang,Haodi Yue,Yuan Liu,Hao Li,Yue Yin,Zhenxing Sun,Ping Cui,Fei Li,Xiuwei Chen,Xin Huang

DOI: https://doi.org/10.3389/fonc.2022.983959

IF: 4.7

2022-07-20

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.898917.].

oncology
Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330

Liqiang Wu,Yunxia Liu,Yazhen Li

DOI: https://doi.org/10.3390/molecules29225257

IF: 4.6

2024-11-08

Molecules

Abstract:Molecules, Vol. 29, Pages 5257: Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330 Molecules doi: 10.3390/molecules29225257 Authors: Liqiang Wu Yunxia Liu Yazhen Li In the original publication [...]

chemistry, multidisciplinary,biochemistry & molecular biology
Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Hae Sang Park,Shinya Yokomizo,Haoran Wang,Sophia Manganiello,Hailey Monaco,Rose McDonnell,Hajin Joanne Kim,Jiyun Rho,Sung Ahn,Jason Gladstone,Harry Jung,Homan Kang,Kai Bao,Satoshi Kashiwagi,Hak Soo Choi

DOI: https://doi.org/10.34133/bmr.0036

2024-05-29

Abstract:[This corrects the article DOI: 10.34133/bmr.0002.].
Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S493466

2024-09-25

Abstract:[This corrects the article DOI: 10.2147/OTT.S57126.].
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"

Elisa Giacomini,Angela Nebbioso,Alfonso Ciotta,Cristina Ianni,Federico Falchi,Marinella Roberti,Manlio Tolomeo,Stefania Grimaudo,Antonietta Di Cristina,Rosaria Maria Pipitone,Lucia Altucci,Maurizio Recanatini

DOI: https://doi.org/10.1021/acsmedchemlett.4c00301

2024-07-03

Abstract:[This corrects the article DOI: 10.1021/ml5000959.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Correction to: Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

DOI: https://doi.org/10.1093/toxres/tfae024

2024-02-28

Abstract:[This corrects the article DOI: 10.1093/toxres/tfad060.].
Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Qian Zhao,Shan-Shan Xiong,Can Chen,Hong-Ping Zhu,Xin Xie,Cheng Peng,Gu He,Bo Han

DOI: https://doi.org/10.3389/fonc.2023.1259550

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.972372.].

oncology
Correction: Synthesis and anticancer evaluation of [ d -Ala]-nocardiotide A

Rani Maharani,Muhamad Imam Muhajir,Jelang Muhammad Dirgantara,Ari Hardianto,Tri Mayanti,Desi Harneti,Nurlelasari,Kindi Farabi,Ace Tatang Hidayat,Unang Supratman,Teruna Siahaan

DOI: https://doi.org/10.1039/d4ra90013h

IF: 4.036

2024-01-01

RSC Advances

Abstract:Correction for ‘Synthesis and anticancer evaluation of [ d -Ala]-nocardiotide A’ by Rani Maharani et al. , RSC Adv. , 2024, 14 , 4097–4104, https://doi.org/10.1039/D4RA00025K.

chemistry, multidisciplinary

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Correction To: Methylseleninic Acid Suppresses Breast Cancer Growth Via the JAK2/STAT3 Pathway

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction to “Homobimetallic Au(I)–Au(I) and Heterotrimetallic Au(I)–Fe(II)–Au(I) Complexes with Dialkyldithiophosphates and Phosphine Ligands: Structural Characterization, DFT Analysis, and Tyrosinase Inhibitory and Biological Effects”

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters

Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Correction to: Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Correction: Synthesis and anticancer evaluation of [ d -Ala]-nocardiotide A